- Exchange: Korea SE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Daewon Pharmaceutical Co Ltd
+ Add to Watchlist003220:KS
11,850 KRW 350 3.04%As of 02:24:00 ET on 05/24/2013.
Snapshot for Daewon Pharmaceutical Co Ltd (003220)
| Open: | 11,500 | Day's Range: | 11,300 - 11,900 | Volume: | 86,280 |
|---|---|---|---|---|---|
| Previous Close: | 11,500 | 52wk Range: | 4,223 - 13,800 | 1-Yr Rtn: | +160.57% |
Key Statistics for 003220
| Current P/E Ratio (ttm) | 19.0292 |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. KOSPI | 0.7317 |
| Earnings Per Share (ttm) | 622.7273 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 184,727.55 |
| Shares Outstanding (M) | 15.59 |
| 30 Day Average Volume | 151,291 |
| Price/Book (mrq) | 1.6275 |
| Price/Sale (ttm) | 1.3239 |
| Dividend Indicated Gross Yield | 0.38% |
| Cash Dividend (KRW) | 45.4545 |
| Last Dividend | 12/27/2012 |
| 5 Year Dividend Growth | -4.71% |
| Next Earnings Announcement | 03/07/2014 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 003220
Company Profile & Key Executives for 003220
Daewon Pharmaceutical Co., Ltd. manufactures and wholesales general and special drugs. The Company's product includes antipyretics, analgesics, respiratory, anti-inflammatory, and metabolic drugs. Daewon also produces health food products.
| Baek Seung-HoChairman | Baek Seung-RyelVice Chairman |
| U Yong-SuChief Executive Officer | Park Sun KeunPresident |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
003220 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page